Burgos Javier S
Centro de Biología Molecular Severo Ochoa - C.S.I.C., Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.
Med Oncol. 2005;22(2):113-21. doi: 10.1385/MO:22:2:113.
The aim of this study was to discuss the relevance of the Epstein-Barr virus (EBV) in the nasopharyngeal carcinoma (NPC), analyzing the variations of several molecules potentially involved in the pathogenesis of this cancer. EBV was detected in all the NPC samples by several techniques including PCR, in situ hybridization, and immunohistochemical methodologies. CD21 membrane receptor was absent after EBV infection, being a differential morphological feature of the tumoral cells. Latent membrane protein-1 (LMP1), an oncogenic viral product, was detected in a high percentage of samples, supporting a role for EBV in the pathogenesis of NPC. Bcl-2, an anti-apoptotic protein up-regulated by LMP1, was also overexpressed, coinciding with the majority of samples positive for LMP1. Finally, p53 presented abnormalities only in a low percentage of samples. These results reinforce the role of the EBV in the NPC discussing several potential mechanisms of pathogenesis in this neoplasia.
本研究的目的是探讨爱泼斯坦-巴尔病毒(EBV)在鼻咽癌(NPC)中的相关性,分析几种可能参与该癌症发病机制的分子变化。通过包括聚合酶链反应(PCR)、原位杂交和免疫组织化学方法在内的多种技术,在所有NPC样本中均检测到EBV。EBV感染后,肿瘤细胞的一个形态学差异特征是CD21膜受体缺失。在高比例的样本中检测到潜伏膜蛋白1(LMP1),这是一种致癌性病毒产物,支持EBV在NPC发病机制中的作用。Bcl-2是一种由LMP1上调的抗凋亡蛋白,也过表达,这与大多数LMP1阳性样本一致。最后,p53仅在低比例的样本中出现异常。这些结果强化了EBV在NPC中的作用,讨论了该肿瘤发病机制的几种潜在机制。